about
Advancements in MR imaging of the prostate: from diagnosis to interventionsMolecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerThe evolving Gleason grading systemThe update of prostatic ductal adenocarcinomaPSA and beyond: alternative prostate cancer biomarkersIncreased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patientsDifferential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer ProgressionMicrornas in prostate cancer: an overview.Mate pair sequencing of whole-genome-amplified DNA following laser capture microdissection of prostate cancer.Identification of a clinically relevant androgen-dependent gene signature in prostate cancerAdvantages of evaluating mean nuclear volume as an adjunct parameter in prostate cancer.Lineage relationship of prostate cancer cell types based on gene expressionIncidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program.Molecular genetics of prostate cancer: new prospects for old challengesOngoing Gleason grade migration in localized prostate cancer and implications for use of active surveillance.Scanometric microRNA array profiling of prostate cancer markers using spherical nucleic acid-gold nanoparticle conjugates.Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transitionBreast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarkerEmerging Themes in Image Informatics and Molecular Analysis for Digital Pathology.Evaluation of prediction models for the staging of prostate cancer.HIF induces human embryonic stem cell markers in cancer cells.High progesterone receptor expression in prostate cancer is associated with clinical failure.Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype.Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populationsHigh SEPT9_i1 protein expression is associated with high-grade prostate cancersDetection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate CancerValidation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohortGene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.Cholesterol and prostate cancer risk: a long-term prospective cohort study.Soluble interleukin-6 receptor to interleukin-6 (sIL‑6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomyAssessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratificatA Prediction Model for ROS1-Rearranged Lung Adenocarcinomas based on Histologic Features.Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone.Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsiesDeveloping a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.Diagnosis of prostatic carcinoma on multiparametric magnetic resonance imaging using shearlet transform
P2860
Q24594047-D234FE6E-42E9-42C7-8CD1-C87471B0AA0EQ26739708-F351D689-AD59-49FB-92E0-83A76F379089Q26752936-AE710C3E-3CF8-4625-9C39-DA599D92395DQ26752939-A26DEBF9-F590-487A-ACD2-723DFF9FB962Q26770646-5822E771-FB06-4B6A-933C-BBE65D415261Q27853341-C68E6C7E-9D89-4FED-A661-0E06CB16CB3DQ28539180-4F0C2E67-6E65-48BD-94DD-C8603FB4BB59Q28550287-A34B6C14-47CA-4F2F-876E-92445C155C27Q30234658-69B7D0A6-C419-4B26-95C1-D3955D1E4790Q31092851-9963B93C-349C-4D82-B5E9-3DE89EEC80ABQ33821752-58C72735-9206-46C4-9AD3-F30B2B9D887DQ33874522-94932FEC-399C-413E-88B4-0660D83DE9D2Q33909346-00A9A90D-EEE1-4B3E-943B-F24D81A95057Q34007656-85DDB9A0-9B8A-4430-963C-C052CBDDDD78Q34127462-55C760AB-97B7-4CAA-9068-CA2323A3DC28Q34135555-D82CF091-6DA0-4979-A89E-CBDE6F3C8D01Q34226854-F06DAC94-BFDE-4592-BA29-7573B889FBD0Q34238517-1F2738E6-69A1-4743-A200-9F2556B3AE4CQ34243311-8FBB9A6D-AEFF-4FE8-B75C-EACAC5F9A9B2Q34472094-A89765AB-923D-4911-93BE-F8E706B869ACQ34534254-04BC0DD2-1D52-4F86-A143-CE0BD16697B2Q35044520-CB8644D4-8C1E-4E43-AD19-DB5127B6FE26Q35085958-2AB512D5-BFAF-4947-82CD-017BF10BD441Q35130208-AD589705-DCB2-45B5-AF77-B48EA018B347Q35141481-59280EEE-B6CF-4A72-8760-939CC30218EEQ35219157-B91BE1E4-0DE9-4B4F-8B3A-8B63261A57C8Q35538243-40E78053-8948-4D73-99C4-35A2200D9C5BQ35610801-51367359-5ED1-4898-965C-79F7A9996852Q35782031-D88D4902-8A14-46B2-AAD3-9E510941459BQ35909631-07AD51D5-46AB-470A-A22B-D9C67CC95C83Q36021088-E5BDDFD0-CBBD-47B3-941E-14DD06CE95EAQ36025180-76115CB7-7183-4068-88F7-6E66D63D43A3Q36106400-35C18AC8-E1EB-4B09-9FBB-39D05ED7347BQ36126540-6981E75A-372F-46C7-8C04-7FE2FD606D3CQ36133745-31FF6BCB-4104-49EF-AAE9-0A1408974507Q36138130-7D6EB4E1-25AD-437D-BD60-60F958D59FD3Q36155367-5C5F3618-BA34-47F3-AAC2-976A924079FEQ36245147-C2688AAC-690E-4268-826E-AB0F13E8ADE8Q36265470-D9F7DF14-DEDB-445B-8683-53DDE56888ABQ36433756-9703FD3E-557B-4A81-925C-898F97B51C85
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on 14 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
An update of the Gleason grading system.
@en
An update of the Gleason grading system.
@nl
type
label
An update of the Gleason grading system.
@en
An update of the Gleason grading system.
@nl
prefLabel
An update of the Gleason grading system.
@en
An update of the Gleason grading system.
@nl
P1476
An update of the Gleason grading system.
@en
P2093
Jonathan I Epstein
P304
P356
10.1016/J.JURO.2009.10.046
P407
P577
2009-12-14T00:00:00Z